본문 바로가기
KERD
논문KCI 등재

Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background/Aims: Solitary hepatocellular carcinoma (HCC) is a subgroup of HCCs. We aimed to establish nomograms for predicting the survival of solitary HCC patients after hepatectomy. Methods: A total of 538 solitary HCC patients were randomly classified into training and validation sets. A Cox model was used to identify predictors of overall survival (OS) in the training set. A nomogram was generated based on these predictors and was validated using the validation set. Results: Tumor size, microvascular invasion, and major vascular invasion were significantly associated with OS in the training set. Nomograms were developed based on these predictors in the multivariate analysis. The C-index was 0.75 for the OS nomogram and 0.72 for the recurrence-free survival nomogram. Compared to the index of conventional staging systems for predicting survival (0.71 for Barcelona Clinic Liver Cancer, 0.66 for the seventh American Joint Committee on Cancer, 0.68 for Cancer of the Liver Italian Program, and 0.70 for Hong Kong Liver Cancer), the index of the OS nomogram was significantly higher. Moreover, the calibration curve fitted well between the predicted and observed survival rate. Similarly, in the validation set, the nomogram discrimination was superior to those of the four staging systems (p<0.001). Conclusions: The nomograms demonstrated good discrimination performance in predicting 3- and 5-year survival rates for solitary HCCs after hepatectomy.

Abstract

Background/Aims: Solitary hepatocellular carcinoma (HCC) is a subgroup of HCCs. We aimed to establish nomograms for predicting the survival of solitary HCC patients after hepatectomy. Methods: A total of 538 solitary HCC patients were randomly classified into training and validation sets. A Cox model was used to identify predictors of overall survival (OS) in the training set. A nomogram was generated based on these predictors and was validated using the validation set. Results: Tumor size, microvascular invasion, and major vascular invasion were significantly associated with OS in the training set. Nomograms were developed based on these predictors in the multivariate analysis. The C-index was 0.75 for the OS nomogram and 0.72 for the recurrence-free survival nomogram. Compared to the index of conventional staging systems for predicting survival (0.71 for Barcelona Clinic Liver Cancer, 0.66 for the seventh American Joint Committee on Cancer, 0.68 for Cancer of the Liver Italian Program, and 0.70 for Hong Kong Liver Cancer), the index of the OS nomogram was significantly higher. Moreover, the calibration curve fitted well between the predicted and observed survival rate. Similarly, in the validation set, the nomogram discrimination was superior to those of the four staging systems (p<0.001). Conclusions: The nomograms demonstrated good discrimination performance in predicting 3- and 5-year survival rates for solitary HCCs after hepatectomy.

참고문헌 (38)

  1. Wang FS, "The global burden of liver disease: the major impact of China", Hepatology, 60, pp.2099~2108 (2014)
  2. Jemal A, "Global cancer statistics", CA Cancer J Clin, 61, pp.69~90 (2011)
  3. Bruix J, "Liver cancer: approaching a personalized care", J Hepatol, 62(1 Suppl), pp.S144~S156 (2015)
  4. Minagawa M, "Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC", UICC TNM systems in a cohort of 13,772 patients in Japan, 2007, pp.245, 909~922
  5. Yau T, "Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma", Gastroenterology, 146, pp.1691~1700.e3 (2014)
  6. Lu XY, "Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior", J Cancer Res Clin Oncol, 137, pp.567~575 (2011)
  7. Pawlik TM, "Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma", Liver Transpl, 11, pp.1086~1092 (2005)
  8. Lim C, "Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma", World J Surg, 38, pp.2910~2918 (2014)
  9. Yang LY, "Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection", Ann Surg, 249, pp.118~123 (2009)
  10. Cai MY, "Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma", Chin J Cancer, 35, pp.80~ (2016)
  11. Roayaie S, "Resection of hepatocellular carcinoma with macroscopic vascular invasion", Ann Surg Oncol, 20, pp.3754~3760 (2013)
  12. Lim KC, "Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria", Ann Surg, 254, pp.108~113 (2011)
  13. Zhong JH, "Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma", Ann Surg, 260, pp.329~340 (2014)
  14. Kokudo T, "Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis", J Hepatol, 61, pp.583~588 (2014)
  15. Zhu SL, "Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis", PLoS One, 9, pp.e115834~ (2014)
  16. Pandey D, "Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection", Ann Surg Oncol, 14, pp.2817~2823 (2007)
  17. Truant S, "Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection", Eur J Surg Oncol, 38, pp.1189~1196 (2012)
  18. Hwang S, "The impact of tumor size on long-term survival outcomes after resection of solitary hepatocellular carcinoma: single-institution experience with 2558 patients", J Gastrointest Surg, 19, pp.1281~1290 (2015)
  19. Zhang H, "Tumor size does not indepen dently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion", World J Surg, 38, pp.947~957 (2014)
  20. Liu PH, "Prognosis of hepatocellular carcinoma: assessment of eleven staging systems", J Hepatol, 64, pp.601~608 (2016)
  21. Tsoulfas G, "Surgical treatment for large hepatocellular carcinoma: does size matter", ANZ J Sur, 82, pp.510~517 (2012)
  22. Ansari D, "Solitary liver lesions of indeterminate malignancy: outcome following surgical resection", Anticancer Res, 32, pp.3961~3964 (2012)
  23. Kim Y, "A nomogram to predict overall survival and disease-free survival after curative resection of gastric adenocarcinoma", Ann Surg Oncol, 22, pp.1828~1835 (2015)
  24. Kent MS, "A Nomogram to predict recurrence and survival of high-risk patients undergoing sublobar resection for lung cancer: an analysis of a multicenter prospective study (ACOSOG Z4032)", Ann Thorac Surg, 102, pp.239~246 (2016)
  25. Seisen T, "Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and", or locally advanced upper tract urothelial carcinoma without metastasis, 2014, pp.114, 733~740
  26. Vickers AJ, "Method for evaluating prediction models that apply the results of randomized trials to individual patients", Trials, 8, pp.14~ (2007)
  27. Yang P, "Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas", Ann Surg, 263, pp.778~786 (2016)
  28. Li J, "Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma", Eur J Cancer, 62, pp.86~95 (2016)
  29. Sumie S, "Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors", Ann Surg Oncol, 15, pp.1375~1382 (2008)
  30. Hyder O, "A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience", JAMA Surg, 149, pp.432~438 (2014)
  31. Hsiao W, "Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma", Int J Urol, 22, pp.264~270 (2015)
  32. Jung YK, "BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A", J Gastroenterol Hepatol, 31, pp.467~474 (2016)
  33. Yang J, "Is hepatectomy for huge hepatocellular carcinoma (≥ 10 cm in diameter) safe and effective? A single-center experience", Asian Pac J Cancer Prev, 15, pp.7069~7077 (2014)
  34. Elnekave E, "Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm", Ann Surg Oncol, 20, pp.2881~2886 (2013)
  35. Liu L, "Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study", Tumour Biol, 37, pp.5327~5335 (2016)
  36. Ho CM, "Long-term survival in patients with T2 hepatocellular carcinoma after primary curative resection can be further stratified by tumor size", Medicine (Baltimore), 93, pp.e203~ (2014)
  37. Huang WJ, "Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma", Langenbecks Arch Surg, 400, pp.725~734 (2015)
  38. Goh BK, "Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system", J Surg Oncol, 113, pp.89~93 (2016)

관련 논문AI추천

Novel Prognostic Nomograms for Hepatocellular Carcinoma Patients with Microvascular Invasion: Experience from a Single CenterBo Li, Liangliang Xu, Lian Li, Lvnan Yan, Mingqing Xu, Ming Zhang, Peng Wang, Tianfu Wen, Xiangyong Hao, Yanfang Zhang거트앤리버 소화기연관학회협의회 · Gut and Liver2019 · 제13권 제6호Evaluation of the American Joint Committee on Cancer (AJCC) 8th Edition Staging System for Hepatocellular Carcinoma in 1,008 Patients with Curative Resection김종만, 박수진, 박철근, 신동현, 조윤아, 최상준, 하상윤대한암학회 · Cancer Research and Treatment2020 · 제52권 제4호Predictors of Micrometastases in Patients with Barcelona Clinic Liver Cancer Classification B Hepatocellular Carcinoma서석원, 최유신연세대학교의과대학 · Yonsei Medical Journal2017 · 제58권 제4호Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent HepatectomyBin Li, Jingxian Shen, Kaiyu Sun, Ming Kuang, Qinghua Cao, Sui Peng, Yifei Wang대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Hepatic Resection Provides Survival Benefit for Selected Intermediate-Stage (BCLC-B) Hepatocellular Carcinoma PatientsChen Bin, Hua Yunpeng, Kuang Ming, Liang Lijian, Li Shaoqiang, Peng Bao Gang, Shen Shunli, Zhang Zhaohui대한암학회 · Cancer Research and Treatment2019 · 제51권 제1호Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer AlgorithmsBeom Jae Lee, Hae Rim Kim, Hyung Joon Yim, Jae Seon Kim, Ji Hoon Kim, Jong Eun Yeon, Jong-Jae Park, Juneyoung Lee, Kwan Soo Byun, Moon Kyung Joo, Sang Jun Suh, Seong Hee Kang, Soon Ho Um, Tae Suk Kim, Yang Jae Yoo, Yeon Seok Seo, Young Kul Jung, Young-Sun Lee, Young-Tae Bak거트앤리버 소화기연관학회협의회 · Gut and Liver2018 · 제12권 제1호

이 간행물의 다른 논문 (21건)